Solasia Pharma K.K. (9SO)
Market Open
12 Aug, 06:02
XFRA XFRA Primary XSTU €
0. 14
-0.01
-4.1667%
€
31.67M Market Cap
- P/E Ratio
- Div Yield
369 Volume
- Eps
€ 0.14
Previous Close Want to track 9SO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Solasia Pharma K.K. (9SO) Statistics
Valuation metrics
Market Cap 31.67M
Enterprise value -6.8M
Trailing P/E (ttm) -
Forward P/E -
PEG ratio -
Price/Sales (ttm) 0.07
Price/Book (mrq) 3.22
Enterprise Value/Revenue -2.93
Enterprise Value/EBITDA 1.53
Overview
Shares outstanding 263.3M
Float 235.77M
Shares short -
% Held by insiders 0.14%
% Held by institutions 0.01%
Average volume (10 days) 64
Average volume (90 days) 57
Price summary
52-Week low 0.09
52-Week high 0.22
Beta 1.22
50-Day moving average 0.16
200-Day moving average 0.16
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2025
Profitability
Profit margin -2.04%
Operating margin -0.43%
Operational effectiveness
Return on assets -0.31%
Return on equity -0.6%
Income Statement
Revenue (ttm) 2.32M
Revenue per share (ttm) 1.81
Quarterly revenue growth (yoy) 0.44%
Gross profit (ttm) 1.12M
EBITDA -4.45M
Net income to common (ttm) -4.74M
Diluted EPS (ttm) -0.02
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 7.5M
Total cash per share (mrq) 5.08
Total debt (mrq) 513.75K
Total Debt/Equity (mrq) 5.42
Current ratio (mrq) 6.06%
Book value per share (mrq) 0.04
Cash Flow
Cash flow statement -4.58M
Levered free cash flow (LFCF) -2.8M
